Physiol Rev AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiol. Rev. 76: 537-592, 1996;
0031-9333/96 $15.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mickelson, J. R.
Right arrow Articles by Louis, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mickelson, J. R.
Right arrow Articles by Louis, C. F.

Physiological Reviews, Vol 76, 537-592, Copyright © 1996 by American Physiological Society

JOURNAL ARTICLE

Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects

J. R. Mickelson and C. F. Louis
Department of Veterinary PathoBiology, University of Minnesota, St. Paul, USA.

Malignant hyperthermia (MH) is a disorder of skeletal muscle in which certain anesthetic agents trigger a sustained elevation in myoplasmic Ca2+ concentration that activates metabolic and contractile activity. This review focuses on the biochemical and physiological alterations in the skeletal muscle of MH-susceptible (MHS) pigs and humans that appear responsible for this inherited disorder. In porcine MH, these studies identified the skeletal muscle sarcoplasmic reticulum Ca2+ release channel gene (RYR1) as the site of the defect. A mutation in this protein results in altered excitation-contraction coupling and secondary changes in porcine muscle structure and function. Although RYR1 mutations have been reported in many MHS human families, there is also significant genetic heterogeneity, and much less is known as to the underlying mechanism responsible for altered human myoplasmic Ca2+ regulation. The effects of caffeine and anesthetic agents on MHS and normal muscle are also discussed to better understand the basis for the in vitro clinical test for this disorder and mechanisms responsible for the initiation and maintenance of MH episodes in susceptible individuals. Finally, we examine the possiblity of a defect in Ca2+ regulation in tissues other than skeletal muscle. Current understanding of the molecular basis of MH elegantly illustrates the successful integration of knowledge obtained from all fields of biological and clinical science.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
D. Jiang, W. Chen, J. Xiao, R. Wang, H. Kong, P. P. Jones, L. Zhang, B. Fruen, and S. R. W. Chen
Reduced Threshold for Luminal Ca2+ Activation of RyR1 Underlies a Causal Mechanism of Porcine Malignant Hyperthermia
J. Biol. Chem., July 25, 2008; 283(30): 20813 - 20820.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
T. Yang, E. Esteve, I. N. Pessah, T. F. Molinski, P. D. Allen, and J. R. Lopez
Elevated resting [Ca2+]i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1591 - C1598.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
M. Franck, P. Figwer, C. Godfraind, M. T. Poirel, A. Khazzaha, and M. M. Ruchoux
Could the pale, soft, and exudative condition be explained by distinctive histological characteristics?
J Anim Sci, March 1, 2007; 85(3): 746 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. M. Duke, P. M. Hopkins, P. J. Halsall, and D. S. Steele
Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia
Br. J. Anaesth., September 1, 2006; 97(3): 320 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. E. Silva
Thermogenic Mechanisms and Their Hormonal Regulation
Physiol Rev, April 1, 2006; 86(2): 435 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
H.-M. Yeh, M.-C. Tsai, Y.-N. Su, R.-C. Shen, J.-J. Hwang, W.-Z. Sun, and L.-P. Lai
Denaturing High Performance Liquid Chromatography Screening of Ryanodine Receptor Type 1 Gene in Patients with Malignant Hyperthermia in Taiwan and Identification of a Novel Mutation (Y522C)
Anesth. Analg., November 1, 2005; 101(5): 1401 - 1406.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. S. Litman and H. Rosenberg
Malignant Hyperthermia: Update on Susceptibility Testing
JAMA, June 15, 2005; 293(23): 2918 - 2924.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
T. Murayama, T. Oba, S. Kobayashi, N. Ikemoto, and Y. Ogawa
Postulated role of interdomain interactions within the type 1 ryanodine receptor in the low gain of Ca2+-induced Ca2+ release activity of mammalian skeletal muscle sarcoplasmic reticulum
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1222 - C1230.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
G. Feriotto, A. Finotti, P. Volpe, S. Treves, S. Ferrari, C. Angelelli, F. Zorzato, and R. Gambari
Myocyte Enhancer Factor 2 Activates Promoter Sequences of the Human A{beta}H-J-J Locus, Encoding Aspartyl-{beta}-Hydroxylase, Junctin, and Junctate
Mol. Cell. Biol., April 15, 2005; 25(8): 3261 - 3275.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. R. Lopez, N. Linares, I. N. Pessah, and P. D. Allen
Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i
Am J Physiol Cell Physiol, March 1, 2005; 288(3): C606 - C612.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Kobayashi, M. L. Bannister, J. P. Gangopadhyay, T. Hamada, J. Parness, and N. Ikemoto
Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor
J. Biol. Chem., February 25, 2005; 280(8): 6580 - 6587.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
R. T. Dirksen and G. Avila
Distinct Effects on Ca2+ Handling Caused by Malignant Hyperthermia and Central Core Disease Mutations in RyR1
Biophys. J., November 1, 2004; 87(5): 3193 - 3204.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. G. Weiss, K. M. S. O'Connell, B. E. Flucher, P. D. Allen, M. Grabner, and R. T. Dirksen
Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling
Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1094 - C1102.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. E. Mycielska and M. B. A. Djamgoz
Cellular mechanisms of direct-current electric field effects: galvanotaxis and metastatic disease
J. Cell Sci., May 1, 2004; 117(9): 1631 - 1639.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
L. Toniolo, M. Patruno, L. Maccatrozzo, M. A. Pellegrino, M. Canepari, R. Rossi, G. D'Antona, R. Bottinelli, C. Reggiani, and F. Mascarello
Fast fibres in a large animal: fibre types, contractile properties and myosin expression in pig skeletal muscles
J. Exp. Biol., May 1, 2004; 207(11): 1875 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
E. M. Gallant, J. Hart, K. Eager, S. Curtis, and A. F. Dulhunty
Caffeine sensitivity of native RyR channels from normal and malignant hyperthermic pigs: effects of a DHPR II-III loop peptide
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C821 - C830.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S Shepherd, F Ellis, J Halsall, P Hopkins, and R Robinson
RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene
J. Med. Genet., March 1, 2004; 41(3): e33 - 33.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
L. Glover, J. J. A. Heffron, and K. Ohlendieck
Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle
J Appl Physiol, January 1, 2004; 96(1): 11 - 18.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Wang, L. Zhang, J. Bolstad, N. Diao, C. Brown, L. Ruest, W. Welch, A. J. Williams, and S. R. W. Chen
Residue Gln4863 within a Predicted Transmembrane Sequence of the Ca2+ Release Channel (Ryanodine Receptor) Is Critical for Ryanodine Interaction
J. Biol. Chem., December 19, 2003; 278(51): 51557 - 51565.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. D. Fessenden, C. F. Perez, S. Goth, I. N. Pessah, and P. D. Allen
Identification of a Key Determinant of Ryanodine Receptor Type 1 Required for Activation by 4-Chloro-m-cresol
J. Biol. Chem., August 1, 2003; 278(31): 28727 - 28735.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Tammaro, A. Bracco, S. Cozzolino, M. Esposito, A. Di Martino, G. Savoia, L. Zeuli, G. Piluso, S. Aurino, and V. Nigro
Scanning for Mutations of the Ryanodine Receptor (RYR1) Gene by Denaturing HPLC: Detection of Three Novel Malignant Hyperthermia Alleles
Clin. Chem., May 1, 2003; 49(5): 761 - 768.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
J. M. Morrissette, J. P. G. Franck, and B. A. Block
Characterization of ryanodine receptor and Ca2+-ATPase isoforms in the thermogenic heater organ of blue marlin (Makaira nigricans)
J. Exp. Biol., March 1, 2003; 206(5): 805 - 812.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
P.D. Allen
Leaky "Feet" and Sudden Death
Circ. Res., August 9, 2002; 91(3): 181 - 182.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. W. Berchtold, H. Brinkmeier, and M. Muntener
Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease
Physiol Rev, July 1, 2000; 80(3): 1215 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. L. Brown, A. N. Pollock, K. G. Couchman, M. Hodges, D. O. Hutchinson, R. Waaka, P. Lynch, T. V. McCarthy, and K. M. Stowell
A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree
Hum. Mol. Genet., June 12, 2000; 9(10): 1515 - 1524.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Yamamoto, R. El-Hayek, and N. Ikemoto
Postulated Role of Interdomain Interaction within the Ryanodine Receptor in Ca2+ Channel Regulation
J. Biol. Chem., April 14, 2000; 275(16): 11618 - 11625.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. El-Hayek, Y. Saiki, T. Yamamoto, and N. Ikemoto
A Postulated Role of the Near Amino-terminal Domain of the Ryanodine Receptor in the Regulation of the Sarcoplasmic Reticulum Ca2+ Channel
J. Biol. Chem., November 19, 1999; 274(47): 33341 - 33347.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
F. Lehmann-Horn and K. Jurkat-Rott
Voltage-Gated Ion Channels and Hereditary Disease
Physiol Rev, October 1, 1999; 79(4): 1317 - 1372.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Balshaw, L. Gao, and G. Meissner
Luminal loop of the ryanodine receptor: A pore-forming segment?
PNAS, March 30, 1999; 96(7): 3345 - 3347.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. J. Lynch, J. Tong, M. Lehane, A. Mallet, L. Giblin, J. J. A. Heffron, P. Vaughan, G. Zafra, D. H. MacLennan, and T. V. McCarthy
A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease
PNAS, March 30, 1999; 96(7): 4164 - 4169.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Leong and D. H. MacLennan
The Cytoplasmic Loops between Domains II and III and Domains III and IV in the Skeletal Muscle Dihydropyridine Receptor Bind to a Contiguous Site in the Skeletal Muscle Ryanodine Receptor
J. Biol. Chem., November 6, 1998; 273(45): 29958 - 29964.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. R. W. Chen, K. Ebisawa, X. Li, and L. Zhang
Molecular Identification of the Ryanodine Receptor Ca2+ Sensor
J. Biol. Chem., June 12, 1998; 273(24): 14675 - 14678.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. R. Fruen, J. R. Mickelson, and C. F. Louis
Dantrolene Inhibition of Sarcoplasmic Reticulum Ca2+ Release by Direct and Specific Action at Skeletal Muscle Ryanodine Receptors
J. Biol. Chem., October 24, 1997; 272(43): 26965 - 26971.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Richter, L. Schleithoff, T. Deufel, F. Lehmann-Horn, and A. Herrmann-Frank
Functional Characterization of a Distinct Ryanodine Receptor Mutation in Human Malignant Hyperthermia-susceptible Muscle
J. Biol. Chem., February 21, 1997; 272(8): 5256 - 5260.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Treves, G. Feriotto, L. Moccagatta, R. Gambari, and F. Zorzato
Molecular Cloning, Expression, Functional Characterization, Chromosomal Localization, and Gene Structure of Junctate, a Novel Integral Calcium Binding Protein of Sarco(endo)plasmic Reticulum Membrane
J. Biol. Chem., December 8, 2000; 275(50): 39555 - 39568.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online